tiprankstipranks
Taysha Gene Therapies (TSHA)
NASDAQ:TSHA
US Market

Taysha Gene Therapies (TSHA) Income Statement

Compare
958 Followers

Taysha Gene Therapies Income Statement

Last quarter (Q3 2024), Taysha Gene Therapies's total revenue was $1.79M, a decrease of -62.33% from the same quarter last year. In Q3, Taysha Gene Therapies's net income was $-25.52M. See Taysha Gene Therapies’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 15.45M$ 2.50M$ 0.00$ 0.00$ 0.00
Gross Profit
$ 15.45M$ 15.00K$ -492.00K$ -9.00K$ 0.00
Operating Expenses
$ 87.89M$ 128.53M$ 173.27M$ 43.00M$ 1.11M
Depreciation and Amortization
$ 1.37M$ 2.49M$ 492.00K$ 9.00K$ 4.46M
EBITDA
$ -105.20M$ -159.73M$ -172.78M$ -42.99M$ 0.00
Operating Income
$ -72.44M$ -162.45M$ -173.27M$ -43.00M$ -1.11M
Other Income/Expenses
$ -39.13M$ -3.57M$ -1.26M$ -17.01M$ 0.00
Pretax Income
$ -111.57M$ -166.01M$ -174.52M$ -60.01M$ -1.11M
Net Income
$ -111.57M$ -169.58M$ -175.46M$ -43.00M$ -1.11M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.96$ -3.86$ -4.66$ -2.43$ -0.03
Diluted EPS
$ -0.96$ -3.86$ -4.66$ -2.43$ -0.03
Weighted Average Shares Outstanding
116.12M 43.95M 37.65M 17.67M 36.99M
Weighted Average Shares Outstanding (Diluted)
116.12M 43.95M 37.65M 17.67M 36.99M
Currency in USD

Taysha Gene Therapies Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis